Inactivated Vaccine Market Growth, Size & Share
Up to now, several Inactivated Vaccine Market have been developed against alarming diseases such as for instance Rabies, Polio, Influenza, Hepatitis A, etc. and they provide excellent protection. An inactivated vaccine contains virus particles, bacteria, and other pathogens that have evolved in culture and are then killed to destroy disease producing capacity. These vaccines might be administered alongside adjuvants to improve the immune response produced. The growth of the inactivated vaccine market is majorly related to the high prevalence of infectious diseases, growing government support for vaccine development, increasing research and development initiatives, and the rising concentrate on immunization. For example, in July 2020, Valneva SE announced it reached an agreement in principle with the U.K. government to provide around 100 million doses of its VLA2001 SARS-CoV-2 (COVID-19) vaccine candidate. Moreover, included in its broader COVID-19 response, Valneva...